Carbonilla, Samuel Scott .

HRN: 12-91-26  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2023
CEFUROXIME 750MG (VIAL)
09/11/2023
09/17/2023
IVT
750mg
Q8hrs
Baiae
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: